Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13K Buy
4,458
+460
+12% +$1.37K ﹤0.01% 2249
2026
Q2
$12.6K Buy
3,998
+1
+0% +$3 ﹤0.01% 2250
2026
Q1
$11.7K Buy
3,997
+486
+14% +$1.39K ﹤0.01% 1972
2025
Q4
$8.67K Buy
3,511
+3
+0.1% +$7 ﹤0.01% 2128
2025
Q3
$7.82K Buy
3,508
+733
+26% +$1.68K ﹤0.01% 2027
2025
Q2
$6.69K Buy
2,775
+768
+38% +$1.87K ﹤0.01% 1957
2025
Q1
$4.68K Buy
2,007
+749
+60% +$1.5K ﹤0.01% 2039
2024
Q4
$2.33K Buy
1,258
+1
+0.1% +$2 ﹤0.01% 2248
2024
Q3
$3.07K Buy
+1,257
New +$2.82K ﹤0.01% 2169

Other funds holding ABEV

BFC Planning's ABEV Position: Q3 2026 in Review

BFC Planning increased its Ambev (ABEV) stake by 12% in Q3 2026, buying an estimated $1.37K and bringing the position to 4,458 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #2249.

BFC Planning first reported a position in ABEV in Q3 2024 and has held it in 9 quarters since. 332 funds tracked by Wall St. Rank hold ABEV as of Q3 2026.

  • BFC Planning held 4,458 shares of Ambev worth $13K as of Q3 2026.
  • BFC Planning bought 460 Ambev shares in Q3 2026, an estimated $1.37K.
  • Ambev made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2249 holding.
  • BFC Planning first reported a position in Ambev in Q3 2024 and has held it in 9 quarters since.
  • 332 funds tracked by Wall St. Rank held Ambev as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.